Αρχειοθήκη ιστολογίου

Πέμπτη 18 Οκτωβρίου 2018

A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)

Shamash, J; Sarker, S-J; Huddart, R; Harland, S; Joffe, JK; Mazhar, D; Birtle, A; ... Vinnicombe, S; + view all Shamash, J; Sarker, S-J; Huddart, R; Harland, S; Joffe, JK; Mazhar, D; Birtle, A; White, J; Chowdhury, K; Wilson, P; Marshall, MR; Vinnicombe, S; - view fewer (2017) A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3). Annals of Oncology , 28 (6) pp. 1333-1338. 10.1093/annonc/mdx071 . Green open access

https://ift.tt/2OwqTha

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου